<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2340-9894</journal-id>
<journal-title><![CDATA[Ars Pharmaceutica (Internet)]]></journal-title>
<abbrev-journal-title><![CDATA[Ars Pharm]]></abbrev-journal-title>
<issn>2340-9894</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2340-98942018000100006</article-id>
<article-id pub-id-type="doi">10.30827/ars.v59i1.7278</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectos adversos asociados al uso de anabolizantes en deportistas: revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Adverse effects associated with the use of anabolic agents in athletes: systematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Urios López]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Miguel Hernández Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[Sant Joan d'Alacant ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (ISABIAL-FISABIO)  ]]></institution>
<addr-line><![CDATA[Alicante ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2018</year>
</pub-date>
<volume>59</volume>
<numero>1</numero>
<fpage>45</fpage>
<lpage>55</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2340-98942018000100006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2340-98942018000100006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2340-98942018000100006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: Revisar la documentación científica sobre los efectos adversos de los agentes anabolizantes en las personas adultas que practican deporte.  Método: Estudio descriptivo transversal y análisis crítico de los trabajos recuperados mediante revisión sistemática. Los datos se obtuvieron de la consulta directa y acceso, vía Internet, a las siguientes bases de datos bibliográficas del ámbito de las ciencias de la salud: MEDLINE (vía PubMed), The Cochrane Library, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINHAL), Web of Science y PsycINFO hasta octubre de 2017. Se consideró adecuado el uso de los Descriptores «Sports», «Anabolic Agents/Adverse effects», utilizando los filtros: «Clinical Trial», «Comparative Study», «Humans» y «Adult:19+years».  Resultados: De las 108 referencias recuperadas, tras aplicar los criterios de inclusión y exclusión, se seleccionaron para la revisión 15 artículos. En los listados bibliográficos se encontró 1 trabajo. Al evaluar la calidad de los artículos seleccionados para la revisión mediante el cuestionario CONSORT, las puntuaciones oscilaron entre 11,5 y 15,5 sobre una puntuación máxima de 25.  Conclusiones: Los trabajos revisados presentaban una obsolescencia superior a lo esperado en el área de las ciencias de la salud. Los artículos estaban redactados preferentemente en inglés. Se observó, en la revisión, que los EAA presentaban efectos adversos, sobre todo a nivel cardiovascular, conductual y aparición de efectos secundarios asociados al consumo de anabolizantes. Si bien, existen discrepancias entre la magnitud de los mismos a nivel cardiovascular y su potencial daño.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective: Review the scientific documentation on the adverse effects of anabolic agents in adults who practice sports.  Method: Descriptive cross-sectional study and critical analysis of the works recovered through systematic review. The data were obtained from direct consultation and access, via the Internet, to the following bibliographic databases in the field of health sciences: MEDLINE (vía PubMed), The Cochrane Library, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINHAL), Web of Science y PsycINFO until October 2017. The use of Descriptors was considered appropriate «Sports», «Anabolic Agents/Adverse effects», using the filters: «Clinical Trial», «Comparative Study», «Humans» y «Adult:19+years».  Results: Of the 108 recovered references, after applying the inclusion and exclusion criteria, 15 articles were selected for review. One job was found in the bibliographic listings. By evaluating the quality of selected articles for review using the CONSORT questionnaire, scores ranged from 11,5 to 15,5 on a maximum score of 25.  Conclusions: The revised work presented a higher obsolescence than expected in the area of health sciences. The articles were written preferably in English. It was observed, that the AAS had adverse effects, especially at the cardiovascular, behavioral level and appearance of side effects associated with the consumption of anabolic agents. Although there are discrepancies between the magnitude of them at the cardiovascular level and their potential damage.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Anabolizantes]]></kwd>
<kwd lng="es"><![CDATA[Efectos Adversos]]></kwd>
<kwd lng="es"><![CDATA[Deportes]]></kwd>
<kwd lng="es"><![CDATA[Revisión sistemática]]></kwd>
<kwd lng="en"><![CDATA[Anabolic Agents]]></kwd>
<kwd lng="en"><![CDATA[Adverse Effects]]></kwd>
<kwd lng="en"><![CDATA[Sports]]></kwd>
<kwd lng="en"><![CDATA[Systematic Review]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Ratamess]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical issues associated with anabolic steroid use: are they exaggerated?]]></article-title>
<source><![CDATA[J Sports Sci Med]]></source>
<year>2006</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>182-93</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iriart]]></surname>
<given-names><![CDATA[JAB]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[TM de]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Body-building, steroid use, and risk perception among young body-builders from a low-income neighborhood in the city of Salvador, Bahia State, Brazil]]></article-title>
<source><![CDATA[Cad Saude Publica]]></source>
<year>2002</year>
<volume>18</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1379-87</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baggish]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Weiner]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Kanayama]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hudson]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Hutter]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction]]></article-title>
<source><![CDATA[Circ Heart Fail]]></source>
<year>2010</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>472-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piacentino]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kotzalidis]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Del]]></surname>
<given-names><![CDATA[Casale A]]></given-names>
</name>
<name>
<surname><![CDATA[Aromatario]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Pomara]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Girardi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review]]></article-title>
<source><![CDATA[Curr Neuropharmacol]]></source>
<year>2015</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>101-21</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Börjesson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gårevik]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[M-L]]></given-names>
</name>
<name>
<surname><![CDATA[Rane]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ekström]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recruitment to doping and help-seeking behavior of eight female AAS users]]></article-title>
<source><![CDATA[Subst Abuse Treat Prev Policy]]></source>
<year>2016</year>
<volume>11</volume>
<page-range>11</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pagonis]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Angelopoulos]]></surname>
<given-names><![CDATA[NV]]></given-names>
</name>
<name>
<surname><![CDATA[Koukoulis]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Hadjichristodoulou]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Toli]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins]]></article-title>
<source><![CDATA[Eur Psychiatry]]></source>
<year>2006</year>
<volume>21</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>563-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gregory]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Guskiewicz]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Self-reported anabolic-androgenic steroids use and musculoskeletal injuries:findings from the center for the study of retired athletes health survey of retired NFL players]]></article-title>
<source><![CDATA[Am J Phys Med Rehabil]]></source>
<year>2009</year>
<volume>88</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>192-200</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Socas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zumbado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Luzardo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature]]></article-title>
<source><![CDATA[Br J Sports Med]]></source>
<year>2005</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e27</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dawson]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drugs in sport - the role of the physician]]></article-title>
<source><![CDATA[J Endocrinol]]></source>
<year>2001</year>
<volume>170</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>55-61</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kersey]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Elliot]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kanayama]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Leone]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Pavlovich]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National Athletic Trainers'Association position statement: anabolic-androgenic steroids]]></article-title>
<source><![CDATA[J Athl Train]]></source>
<year></year>
<volume>47</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>567-88</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cobos-Carbo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Augustovski]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Declaración CONSORT 2010:actualización de la lista de comprobación para informar ensayos clínicos aleatorizados de grupos paralelos]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2011</year>
<volume>137</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>213-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[da]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[da]]></surname>
<given-names><![CDATA[Cruz LA]]></given-names>
</name>
<name>
<surname><![CDATA[Cerqueira]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[de]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Meireles]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Micronucleus as biomarkers of cancer risk in anabolic androgenic steroids users]]></article-title>
<source><![CDATA[Hum Exp Toxicol]]></source>
<year>2017</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>302-10</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ili&#263;]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Djordjevi&#263;]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Stankovi&#263;]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Vlahovi&#263;-Stipac]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Putnikovi&#263;]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Babi&#263;]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of anabolic androgenic steroids abuse and type of training on left ventricular remodeling and function in competitive athletes]]></article-title>
<source><![CDATA[Vojnosanit Pregl]]></source>
<year>2014</year>
<volume>71</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>383-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kasikcioglu]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Oflaz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Umman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bugra]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Androgenic anabolic steroids also impair right ventricular function]]></article-title>
<source><![CDATA[Int J Cardiol]]></source>
<year>2009</year>
<volume>134</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>123-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D'Andrea]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Caso]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Salerno]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Scarafile]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[Corato G]]></given-names>
</name>
<name>
<surname><![CDATA[Mita]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids:a Doppler myocardial and strain imaging analysis]]></article-title>
<source><![CDATA[Br J Sports Med]]></source>
<year>2007</year>
<volume>41</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>149-55</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Grace]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Boobier]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Hullin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kicman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cowan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Homocysteine induced cardiovascular events:a consequence of long term anabolic-androgenic steroid (AAS) abuse]]></article-title>
<source><![CDATA[Br J Sports Med]]></source>
<year>2006</year>
<volume>40</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>644-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Climstein]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[O'Shea]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[DeBeliso]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of anabolic-androgenic steroids upon resting and peak exercise left ventricular heart wall motion kinetics in male strength and power athletes]]></article-title>
<source><![CDATA[J Sci Med Sport]]></source>
<year>2003</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>387-97</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grace]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sculthorpe]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS)]]></article-title>
<source><![CDATA[J Sci Med Sport]]></source>
<year>2003</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>307-12</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iñigo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Arrimadas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Arroyo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[43 cycles of anabolic steroid treatment studied in athletes:the uses and secondary effects]]></article-title>
<source><![CDATA[Rev Clin Esp]]></source>
<year>2000</year>
<volume>200</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>133-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hislop]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Ratanjee]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Soule]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Marais]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men]]></article-title>
<source><![CDATA[Eur J Endocrinol]]></source>
<year>1999</year>
<volume>141</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>40-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giorgi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weatherby]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Muscular strength, body composition and health responses to the use of testosterone enanthate:a double blind study]]></article-title>
<source><![CDATA[J Sci Med Sport]]></source>
<year>1999</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>341-55</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palatini]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Giada]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Garavelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sinisi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mario]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Michieletto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular effects of anabolic steroids in weight-trained subjects]]></article-title>
<source><![CDATA[J Clin Pharmacol]]></source>
<year>1996</year>
<volume>36</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1132-40</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Porcerelli]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Sandler]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Narcissism and empathy in steroid users]]></article-title>
<source><![CDATA[Am J Psychiatry]]></source>
<year>1995</year>
<volume>152</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1672-4</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pope]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Kouri]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Hudson]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial]]></article-title>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>2000</year>
<volume>57</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>133-40</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Kicman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cowan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hullin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency]]></article-title>
<source><![CDATA[Horm Res]]></source>
<year>2008</year>
<volume>69</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>343-54</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Babigian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Silverman]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of gynecomastia due to use of anabolic steroids in bodybuilders]]></article-title>
<source><![CDATA[Plast Reconstr Surg]]></source>
<year>2001</year>
<volume>107</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>240-2</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Melnik]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Grabbe]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abuse of anabolic-androgenic steroids and bodybuilding acne:an underestimated health problem]]></article-title>
<source><![CDATA[J Dtsch Dermatol Ges]]></source>
<year>2007</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>110-7</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O'Sullivan]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Casey]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Day]]></surname>
<given-names><![CDATA[RO]]></given-names>
</name>
<name>
<surname><![CDATA[Corrigan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wodak]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anabolic-androgenic steroids: medical assessment of present, past and potential users]]></article-title>
<source><![CDATA[Med J Aust]]></source>
<year>2000</year>
<volume>173</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>323-7</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franco-López]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Culebras]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Publicar en castellano, o en cualquier otro idioma que no sea inglés, negativo para el factor de impacto y citaciones]]></article-title>
<source><![CDATA[J Negat No Posit Results]]></source>
<year>2016</year>
<numero>2</numero>
<issue>2</issue>
<page-range>65-70</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wanden-Berghe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis bibliométrico de la producción científica, indizada en MEDLINE, sobre los servicios de salud proporcionados por las unidades de hospitalización a domicilio]]></article-title>
<source><![CDATA[Hosp Domic]]></source>
<year>2017</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-34</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ip]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Barnett]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tenerowicz]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Women and anabolic steroids: an analysis of a dozen users]]></article-title>
<source><![CDATA[Clin J Sport Med]]></source>
<year>2010</year>
<volume>20</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>475-81</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sahraian]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mottamedi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Azimi]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Moghimi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Androgen-induced cerebral venous sinus thrombosis in a young body builder:case report]]></article-title>
<source><![CDATA[BMC Neurol]]></source>
<year>2004</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Pagliaro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pickar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wolkowitz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Rubinow]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuropsychiatric effects of anabolic steroids in male normal volunteers]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1993</year>
<volume>269</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>2760-4</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Derman]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of sex steroids on women's health: implications for practitioners]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>1995</year>
<volume>98</volume>
<numero>1A</numero>
<issue>1A</issue>
<page-range>137S-43S</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavlatos]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Fultz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Monberg]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vootkur]]></surname>
<given-names><![CDATA[A. Pharmd]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid]]></article-title>
<source><![CDATA[Clin Ther]]></source>
<year>2001</year>
<volume>23</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>789-801</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[C-C]]></given-names>
</name>
<name>
<surname><![CDATA[Sadick]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Diwan]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia]]></article-title>
<source><![CDATA[J Cutan Pathol]]></source>
<year>2005</year>
<volume>32</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>567-71</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domingo-Pueyo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wanden-Berghe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of occupational exposure to chromium and its compounds: a systematic review]]></article-title>
<source><![CDATA[Arch Prev Riesgos Laborales]]></source>
<year>2014</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>142-53</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bruno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anabolic steroids and their abuse in sports]]></article-title>
<source><![CDATA[Clin Ter]]></source>
<year>1990</year>
<volume>135</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>159-72</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alén]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rahkila]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduced high-density lipoprotein-cholesterol in power athletes:use of male sex hormone derivates, an atherogenic factor]]></article-title>
<source><![CDATA[Int J Sports Med]]></source>
<year>1984</year>
<volume>5</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>341-2</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brennan]]></surname>
<given-names><![CDATA[BP]]></given-names>
</name>
<name>
<surname><![CDATA[Kanayama]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hudson]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Pope]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human growth hormone abuse in male weightlifters]]></article-title>
<source><![CDATA[Am J Addict]]></source>
<year>2011</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-13</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fanton]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Belhani]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vaillant]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Tabib]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Descotes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heart lesions associated with anabolic steroid abuse:comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits]]></article-title>
<source><![CDATA[Exp Toxicol Pathol]]></source>
<year>2009</year>
<volume>61</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>317-23</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bond]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[PY]]></given-names>
</name>
<name>
<surname><![CDATA[Pope]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids]]></article-title>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>1995</year>
<volume>37</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>241-5</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
